Novel neurosteroid hypnotic blocks T-type calcium channel-dependent rebound burst firing and suppresses long-term potentiation in the rat subiculum.


Journal

British journal of anaesthesia
ISSN: 1471-6771
Titre abrégé: Br J Anaesth
Pays: England
ID NLM: 0372541

Informations de publication

Date de publication:
May 2019
Historique:
received: 30 05 2018
revised: 17 12 2018
accepted: 21 12 2018
pubmed: 28 3 2019
medline: 23 4 2019
entrez: 28 3 2019
Statut: ppublish

Résumé

Hypnotics and general anaesthetics impair memory by altering hippocampal synaptic plasticity. We recently reported on a neurosteroid analogue with potent hypnotic activity [(3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile; 3β-OH], which does not cause developmental neurotoxicity in rat pups. Here, we investigated the effects of 3β-OH on neuronal excitability in the subiculum, the major output structure of the hippocampal formation, and synaptic plasticity at two key hippocampal synapses in juvenile rats. Biophysical properties of isolated T-type calcium currents (T-currents) in the rat subiculum were investigated using acute slice preparations. Subicular T-type calcium channel (T-channel) subtype mRNA expression was compared using qRT-PCR. Using electrophysiological recordings, we examined the effects of 3β-OH and an endogenous neuroactive steroid, allopregnanolone (Allo), on T-currents and burst firing properties of subicular neurones, and on the long-term potentiation (LTP) in CA3-CA1 and CA1-subiculum pathways. Biophysical and molecular studies confirmed that Ca Neurosteroid effects on T-channels modulate hippocampal output and provide possible molecular mechanisms for the amnestic action of the novel hypnotic 3β-OH. Effects on T-channels in the subiculum provide a novel target for amnestic effects of hypnotics.

Sections du résumé

BACKGROUND BACKGROUND
Hypnotics and general anaesthetics impair memory by altering hippocampal synaptic plasticity. We recently reported on a neurosteroid analogue with potent hypnotic activity [(3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile; 3β-OH], which does not cause developmental neurotoxicity in rat pups. Here, we investigated the effects of 3β-OH on neuronal excitability in the subiculum, the major output structure of the hippocampal formation, and synaptic plasticity at two key hippocampal synapses in juvenile rats.
METHODS METHODS
Biophysical properties of isolated T-type calcium currents (T-currents) in the rat subiculum were investigated using acute slice preparations. Subicular T-type calcium channel (T-channel) subtype mRNA expression was compared using qRT-PCR. Using electrophysiological recordings, we examined the effects of 3β-OH and an endogenous neuroactive steroid, allopregnanolone (Allo), on T-currents and burst firing properties of subicular neurones, and on the long-term potentiation (LTP) in CA3-CA1 and CA1-subiculum pathways.
RESULTS RESULTS
Biophysical and molecular studies confirmed that Ca
CONCLUSIONS CONCLUSIONS
Neurosteroid effects on T-channels modulate hippocampal output and provide possible molecular mechanisms for the amnestic action of the novel hypnotic 3β-OH. Effects on T-channels in the subiculum provide a novel target for amnestic effects of hypnotics.

Identifiants

pubmed: 30916017
pii: S0007-0912(19)30072-8
doi: 10.1016/j.bja.2019.01.029
pmc: PMC6549045
pii:
doi:

Substances chimiques

3-hydroxyandrostane-17-carbonitrile 0
Androstanols 0
Calcium Channel Blockers 0
Calcium Channels, T-Type 0
Hypnotics and Sedatives 0
Nitriles 0
RNA, Messenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

643-651

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM102525
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH114866
Pays : United States

Informations de copyright

Copyright © 2019 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.

Références

J Neurosci. 1999 Mar 15;19(6):1895-911
pubmed: 10066243
Mol Pharmacol. 2000 Jul;58(1):98-108
pubmed: 10860931
Hippocampus. 2000;10(4):447-56
pubmed: 10985284
J Neurophysiol. 2000 Nov;84(5):2398-408
pubmed: 11067982
Anesthesiology. 2001 Jun;94(6):1058-65
pubmed: 11465598
Neurosci Lett. 2002 May 24;324(3):181-4
pubmed: 12009518
Physiol Rev. 2003 Jan;83(1):117-61
pubmed: 12506128
Brain Res. 1992 Oct 9;593(1):124-7
pubmed: 1458314
Mol Pharmacol. 2004 Nov;66(5):1223-35
pubmed: 15280444
Nat Rev Neurosci. 2004 Sep;5(9):709-20
pubmed: 15322529
Br J Pharmacol. 2005 Jan;144(1):59-70
pubmed: 15644869
Pain. 2005 Apr;114(3):429-43
pubmed: 15777868
Anesthesiology. 2005 Aug;103(2):318-26
pubmed: 16052114
J Neurophysiol. 2006 Jun;95(6):3297-308
pubmed: 16554502
Eur J Neurosci. 2006 Nov;24(9):2581-94
pubmed: 17100846
Eur J Neurosci. 2007 Oct;26(7):1881-8
pubmed: 17883414
J Comp Neurol. 2008 Feb 1;506(4):535-47
pubmed: 18067146
Ann N Y Acad Sci. 2007 Dec;1122:83-94
pubmed: 18077566
Anesthesiology. 2008 Mar;108(3):447-56
pubmed: 18292682
Anesthesiology. 2008 Nov;109(5):775-81
pubmed: 18946287
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):782-90
pubmed: 19393282
Anesthesiology. 2010 Dec;113(6):1299-309
pubmed: 21042201
Channels (Austin). 2010 Nov-Dec;4(6):475-82
pubmed: 21139420
Channels (Austin). 2010 Nov-Dec;4(6):518-22
pubmed: 21164281
Neuropharmacology. 2012 Aug;63(2):266-73
pubmed: 22491022
Prog Neurobiol. 2013 Jul-Aug;106-107:1-16
pubmed: 23583307
Ann Fr Anesth Reanim. 2013 Oct;32(10):e135-41
pubmed: 24011619
Br J Anaesth. 1989 Mar;62(3):301-10
pubmed: 2539171
J Neurosci. 2015 Jul 1;35(26):9707-16
pubmed: 26134653
J Physiol. 2017 Oct 1;595(19):6327-6348
pubmed: 28744923
Br J Anaesth. 2018 Apr;120(4):768-778
pubmed: 29576117
Nature. 1993 Jan 7;361(6407):31-9
pubmed: 8421494
J Neurosci. 1997 Jan 1;17(1):277-95
pubmed: 8987755
J Neurophysiol. 1998 Jan;79(1):240-52
pubmed: 9425195
Neuropsychopharmacology. 1999 Feb;20(2):106-18
pubmed: 9885791

Auteurs

Srdjan M Joksimovic (SM)

Department of Anesthesiology, University of Colorado, School of Medicine, Aurora, CO, USA. Electronic address: srdan.joksimovic@ucdenver.edu.

Yukitoshi Izumi (Y)

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, USA.

Sonja Lj Joksimovic (SL)

Department of Anesthesiology, University of Colorado, School of Medicine, Aurora, CO, USA.

Vesna Tesic (V)

Department of Anesthesiology, University of Colorado, School of Medicine, Aurora, CO, USA.

Kathiresan Krishnan (K)

Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.

Betelehem Asnake (B)

Department of Anesthesiology and Pain Medicine, University of California, Davis, CA, USA.

Vesna Jevtovic-Todorovic (V)

Department of Anesthesiology, University of Colorado, School of Medicine, Aurora, CO, USA.

Douglas F Covey (DF)

Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, USA; Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA.

Charles F Zorumski (CF)

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA; Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, USA.

Slobodan M Todorovic (SM)

Department of Anesthesiology, University of Colorado, School of Medicine, Aurora, CO, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH